Vera Therapeutics, Inc.(VERA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

VERA Vera Therapeutics, Inc.

Not Yet Opened 09-03 16:00:00 EDT

34.99

-0.67

-1.88%

盘后34.99

+0.000.00%

19:30 EDT

High35.74	Low34.53	Vol929.05K
Open35.53	D1 Closing35.66	Amplitude3.39%
Mkt Cap2.51B	Tradable Cap2.20B	Total Shares71.71M
T/O32.62M	T/O Rate1.48%	Tradable Shares62.80M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"VERA","market":"US","secType":"STK","nameCN":"Vera Therapeutics, Inc.","latestPrice":34.99,"timestamp":1788465600000,"preClose":35.66,"halted":0,"volume":929047,"hourTrading":{"tag":"盘后","latestPrice":34.99,"preClose":34.99,"latestTime":"19:30 EDT","volume":28502,"amount":997284.6901,"timestamp":1788478207973,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.01878855860908566,"floatShares":62802805,"shares":71713905,"eps":-5.898389,"marketStatus":"Not Yet Opened","change":-0.67,"latestTime":"09-03 16:00:00 EDT","open":35.53,"high":35.74,"low":34.53,"amount":32619163.478356,"amplitude":0.033932,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-5.898389,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1788508800000},"marketStatusCode":0,"adr":0,"listingDate":1620964800000,"exchange":"NASDAQ","adjPreClose":35.66,"preHourTrading":{"tag":"盘前","latestPrice":35.53,"preClose":35.66,"latestTime":"09:29 EDT","volume":2213,"amount":77960.300929,"timestamp":1788442199999,"change":-0.13,"changeRate":-0.003646,"amplitude":0.027201},"postHourTrading":{"tag":"盘后","latestPrice":34.99,"preClose":34.99,"latestTime":"19:30 EDT","volume":28502,"amount":997284.6901,"timestamp":1788478207973,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.40737,"impliedVol":1.0883,"impliedVolPercentile":0.754},"requestUrl":"/m/hq/s/VERA/tweets","defaultTab":"tweets","newsList":[{"id":"2664855148","title":"Vera Therapeutics Management Presents at Cantor Global Healthcare Conference 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2664855148","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664855148?lang=en_us&edition=fundamental","pubTime":"2026-09-01 19:30","pubTimestamp":1788262252,"startTime":"0","endTime":"0","summary":"Vera Therapeutics management presents at Cantor Global Healthcare Conference 2026Vera Therapeutics will present at the Cantor Global Healthcare Conference on Sept. 10, 2026 in New York.Management is a","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nNDL55VmY1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1668664300.SGD","LU1989772840.SGD","BK4516","IE00B64PRP62.GBP","KBWB","LU0528227936.USD","LU0912757837.SGD","BK4539","LU2210149790.SGD","LU2264538146.SGD","LU2133065610.SGD","BCDF","LU0053666078.USD","LU0234570918.USD","LU1244550577.SGD","SG9999014005.SGD","SG9999014013.SGD","LU0210528500.USD","LU2095319765.USD","BK4581","LU1989772923.USD","IAI","LU2357305700.SGD","LU1064131342.USD","LU1244550221.USD","LU0158827948.USD","LU0795875086.SGD","LU1988902786.USD","IE00BKVL7J92.USD","BK4112","IE00BQXX3D17.EUR","LU0557290698.USD","BK4504","LU0314104364.USD","LU2487616109.SGD","LU1720051108.HKD","LU0320765646.SGD","LU0158827781.USD","BK4139","LU1732799900.SGD","IE00BGHQF748.EUR","BK4588","LU0106261372.USD","SG9999014021.USD","VERA","LU2089283258.USD","IE00BQXX3F31.USD","IE00BQXX3C00.GBP","IE00B3S45H60.SGD","NDAQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664685542","title":"Vera Therapeutics to Participate at Upcoming Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2664685542","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664685542?lang=en_us&edition=fundamental","pubTime":"2026-09-01 19:30","pubTimestamp":1788262200,"startTime":"0","endTime":"0","summary":"BRISBANE, Calif., Sept.  01, 2026 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a commercial-stage biotechnology company, today announced that the Company’s management team will present ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/01/3354009/0/en/vera-therapeutics-to-participate-at-upcoming-investor-conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VERA","LU2324357040.USD","BK4139","BK4588","BK4539","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662201631","title":"3 Best Stocks With 100%+ Upside to Buy This Week, According to Analysts","url":"https://stock-news.laohu8.com/highlight/detail?id=2662201631","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662201631?lang=en_us&edition=fundamental","pubTime":"2026-08-25 06:05","pubTimestamp":1787609117,"startTime":"0","endTime":"0","summary":"Analysts see strong momentum in some stocks this week, including Fervo Energy ($FRVO), Vera Therapeutics ($VERA), and Hut 8 ($HUT). While each stoc...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/3-best-stocks-with-100-upside-to-buy-this-week-according-to-analysts-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/3-best-stocks-with-100-upside-to-buy-this-week-according-to-analysts-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BLCK","BK4600","BK4595","HUTG","VERA","BK4585","BK4133","BK4588","DAPP","BK4023","HUT","MNRS","FRVO","LU2324357040.USD","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660343910","title":"Jefferies Sticks to Its Buy Rating for Vera Therapeutics (VERA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2660343910","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660343910?lang=en_us&edition=fundamental","pubTime":"2026-08-18 00:35","pubTimestamp":1786984544,"startTime":"0","endTime":"0","summary":"Jefferies analyst maintained a Buy rating on Vera Therapeutics today and set a price target of $59.00. In addition to Jefferies, Vera Therapeutics ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/jefferies-sticks-to-its-buy-rating-for-vera-therapeutics-vera-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/jefferies-sticks-to-its-buy-rating-for-vera-therapeutics-vera-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VERA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660389314","title":"Vera Therapeutics Price Target Maintained with a $34.00/Share by Wedbush","url":"https://stock-news.laohu8.com/highlight/detail?id=2660389314","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660389314?lang=en_us&edition=fundamental","pubTime":"2026-08-17 21:20","pubTimestamp":1786972800,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/VERA/analyst-ratings","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VERA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659512589","title":"Vera Rises on Early Kidney Function Data in FDA Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2659512589","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659512589?lang=en_us&edition=fundamental","pubTime":"2026-08-15 01:41","pubTimestamp":1786729297,"startTime":"0","endTime":"0","summary":"BUZZ-Vera rises on early kidney function data in FDA review** Shares of Vera TherapeuticsVERA.Orise 10.4% to $31.89** U.S. FDA published its review documents supporting theaccelerated approvalof Vera'","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nL4N44B15W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4585","BK4539","VERA","BK4139","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658397964","title":"Analyst Maintains Buy on Vera Therapeutics, Cutting Trutakna Price Target to $90 Amid Rising IgAN Competition","url":"https://stock-news.laohu8.com/highlight/detail?id=2658397964","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658397964?lang=en_us&edition=fundamental","pubTime":"2026-08-12 18:36","pubTimestamp":1786530970,"startTime":"0","endTime":"0","summary":"Vera Therapeutics, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Arthur He CFA from H.C. Wainwright maintain...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/analyst-maintains-buy-on-vera-therapeutics-cutting-trutakna-price-target-to-90-amid-rising-igan-competition-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/analyst-maintains-buy-on-vera-therapeutics-cutting-trutakna-price-target-to-90-amid-rising-igan-competition-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VERA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658926373","title":"Analyst Sees Vera Well Positioned for Trutakna IgAN Launch, Sustained Uptake and Long‑Term Value Creation","url":"https://stock-news.laohu8.com/highlight/detail?id=2658926373","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658926373?lang=en_us&edition=fundamental","pubTime":"2026-08-12 13:26","pubTimestamp":1786512361,"startTime":"0","endTime":"0","summary":"Ritu Baral, an analyst from TD Cowen, maintained the Buy rating on Vera Therapeutics. The associated price target is $78.00. Ritu Baral has given h...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/analyst-sees-vera-well-positioned-for-trutakna-igan-launch-sustained-uptake-and-longterm-value-creation-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/analyst-sees-vera-well-positioned-for-trutakna-igan-launch-sustained-uptake-and-longterm-value-creation-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","VERA","BK4585","BK4539","LU2324357040.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658919060","title":"Jefferies Sticks to Its Buy Rating for Vera Therapeutics (VERA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658919060","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658919060?lang=en_us&edition=fundamental","pubTime":"2026-08-11 22:56","pubTimestamp":1786460175,"startTime":"0","endTime":"0","summary":"In a report released today, from Jefferies maintained a Buy rating on Vera Therapeutics, with a price target of $59.00. In addition to Jefferies, V...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/jefferies-sticks-to-its-buy-rating-for-vera-therapeutics-vera-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/jefferies-sticks-to-its-buy-rating-for-vera-therapeutics-vera-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VERA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658157989","title":"Vera Therapeutics Price Target Cut to $34.00/Share from $43.00 by Wedbush","url":"https://stock-news.laohu8.com/highlight/detail?id=2658157989","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658157989?lang=en_us&edition=fundamental","pubTime":"2026-08-11 21:48","pubTimestamp":1786456080,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/VERA/analyst-ratings","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VERA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658992431","title":"Vera Therapeutics, Inc. : Wedbush Cuts Target Price to $34 from $43","url":"https://stock-news.laohu8.com/highlight/detail?id=2658992431","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658992431?lang=en_us&edition=fundamental","pubTime":"2026-08-11 19:20","pubTimestamp":1786447208,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nFWN44811J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4588","BK4585","BK4539","VERA","BK4139","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658150992","title":"Wedbush Adjusts Price Target on Vera Therapeutics to $34 From $43, Maintains Neutral Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2658150992","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658150992?lang=en_us&edition=fundamental","pubTime":"2026-08-11 19:17","pubTimestamp":1786447057,"startTime":"0","endTime":"0","summary":"Vera Therapeutics (VERA) has an average rating of buy and mean price target of $81.86, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major b","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["VERA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658996348","title":"Vera Therapeutics (VERA) Gets a Buy from Bank of America Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2658996348","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658996348?lang=en_us&edition=fundamental","pubTime":"2026-08-11 17:15","pubTimestamp":1786439753,"startTime":"0","endTime":"0","summary":"Bank of America Securities analyst Dina Ramadane reiterated a Buy rating on Vera Therapeutics yesterday and set a price target of $66.00. The compa...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/vera-therapeutics-vera-gets-a-buy-from-bank-of-america-securities-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/vera-therapeutics-vera-gets-a-buy-from-bank-of-america-securities-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BFXG1179.USD","LU1506573853.SGD","IE00BLSP4239.USD","LU0314106906.USD","IE00BKVL7J92.USD","BK4539","LU1496350502.SGD","BAC","IE00B19Z3B42.SGD","LU1894683264.USD","PGF","KBWB","LU2596442595.SGD","LU2265009873.SGD","LU0211331839.USD","LU0971096721.USD","LU1291159041.SGD","LU1880398471.USD","LU0128525689.USD","BK4504","LU1162221912.USD","VERA","BK4588","FNCL","LU0203347892.USD","LU1366192091.USD","IE00BBT3K403.USD","LU0130517989.USD","LU0234570918.USD","LU1791807156.HKD","LU0683600562.USD","XLF","LU1883839398.USD","LU0170899867.USD","LU2129689605.HKD","LU0306806265.USD","UYG","LU1267930227.SGD","VFH","BK4534","BK4582","LU1880398554.USD","FTXO","IE00BZ1G4Q59.USD","IYF","LU0787776722.HKD","LU1894683348.USD","IYG","TFNS","LU1989771016.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658954473","title":"Vera Therapeutics Q2 Loss Widens Less than Expected","url":"https://stock-news.laohu8.com/highlight/detail?id=2658954473","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658954473?lang=en_us&edition=fundamental","pubTime":"2026-08-11 05:07","pubTimestamp":1786396033,"startTime":"0","endTime":"0","summary":"Vera Therapeutics Q2 loss widens less than expectedOverviewUS biotech's Q2 EPS widened less than analyst expectationsCompany launched TRUTAKNA, first FDA-approved BAFF and APRIL inhibitor for IgA neph","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nL1N4470ZZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PROK","LU2324357040.USD","VERA","SANA","BK4539","BK4139","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658954785","title":"Vera Therapeutics Q2 EPS $(1.52) Beats $(1.61) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2658954785","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658954785?lang=en_us&edition=fundamental","pubTime":"2026-08-11 05:06","pubTimestamp":1786395966,"startTime":"0","endTime":"0","summary":"Vera Therapeutics (NASDAQ:VERA) reported quarterly losses of $(1.52) per share which beat the analyst consensus estimate of $(1.61) by 5.59 percent. This is a 26.67 percent decrease over losses of $(1.20) per share from","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/61095716/vera-therapeutics-q2-eps-1-52-beats-1-61-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Vera Therapeutics Q2 EPS $(1.52) Beats $(1.61) Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VERA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658951980","title":"Top News Today/Canada: Barrick Settles Newmont Dispute, Clearing Way to List Its Gold Assets","url":"https://stock-news.laohu8.com/highlight/detail?id=2658951980","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658951980?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:33","pubTimestamp":1786393980,"startTime":"0","endTime":"0","summary":"HEADLINESBarrick Mining Settles Newmont Nevada Dispute for $1.95 Billion, Clearing Way to List its Gold AssetsBarrick Mining has settled a long-standing dispute with rival Newmont over their Nevada op","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4109","GHI","BK4175","MEMS","CRIS","VERA","CAH","IMNN","OBIO","BK4123","SLAB","AMTM","STIM","BK4023","KLXE","LU0240877869.USD","TNGX","DRIO","BSIN","RXT","NVRI","SLSN","VSTS","JBI","SYPR","MASS","TCRX","PESI","DOMH","BK4127","APRE","ARMK","MIDD","LVWD","HBIO","IE00B3S45H60.SGD","BK4167","SG9999001440.SGD","IMUX","FLOC","BWEN","REFI","MEDI","BK4179","CANC","LEGN","LU0154236417.USD","ACCS","WHF","AVXL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658959119","title":"Vera Therapeutics Q2 FY26 Net Loss Widens to $109.5 Million; Loss Per Share Rises to $1.52","url":"https://stock-news.laohu8.com/highlight/detail?id=2658959119","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658959119?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:15","pubTimestamp":1786392943,"startTime":"0","endTime":"0","summary":"Vera Therapeutics Q2 FY26 net loss widens to $109.5 million; loss per share rises to $1.52Vera Therapeutics posted a net loss of USD 109.5 million, or USD 1.52 per share, in Q2 2026, widening from a l","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nNDL8FmLrk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU2324357040.USD","VERA","BK4139","BK4539","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658954583","title":"Vera Therapeutics, - Anticipates Sbla Submission to FDA for Trutakna in Q4 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2658954583","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658954583?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:05","pubTimestamp":1786392302,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nTUABFKNVX:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","VERA","BK4588","LU2324357040.USD","BK4585","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658952631","title":"Vera Therapeutics Provides Business Update and Reports Second Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2658952631","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658952631?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:05","pubTimestamp":1786392300,"startTime":"0","endTime":"0","summary":"TRUTAKNA granted accelerated approval by U.S. Food and Drug Administration (FDA) in adult patients with primary IgA nephropathy (IgAN) at risk for disease progression.Alignment with FDA on earlier ORI","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/10/3342203/0/en/vera-therapeutics-provides-business-update-and-reports-second-quarter-2026-financial-results.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TACI","LABU","LU2324357040.USD","BK4585","VERA","BK4588","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657626816","title":"Vera Therapeutics Grants Inducement Equity Awards to New Chief Regulatory Officer, Hires","url":"https://stock-news.laohu8.com/highlight/detail?id=2657626816","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657626816?lang=en_us&edition=fundamental","pubTime":"2026-08-08 04:06","pubTimestamp":1786133197,"startTime":"0","endTime":"0","summary":"Vera Therapeutics grants inducement equity awards to new chief regulatory officer, hiresVera Therapeutics set inducement equity awards under its 2024 Inducement Plan for new hires in early August 2026","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nNDL93xfny:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCDF","BK4539","SG9999014013.SGD","VERA","BK4588","IE00BGHQF748.EUR","IE00BN0W2W23.USD","IE00BN0W2V16.EUR","LU2210150020.SGD","LU0314104364.USD","LU2324357040.USD","SG9999014039.USD","IE00BKPKM429.USD","BK4112","SG9999014005.SGD","SG9999014021.USD","IE00B3QW5Z07.USD","NDAQ","LU2095319765.USD","BK4139","IE00B64PRP62.GBP","LU2210149790.SGD","IE00BN0W2T93.GBP","BK4585"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.veratx.com","stockEarnings":[{"period":"1week","weight":0.0113},{"period":"1month","weight":0.1683},{"period":"3month","weight":0.0836},{"period":"6month","weight":-0.1044},{"period":"1year","weight":0.524},{"period":"ytd","weight":-0.309}],"compareEarnings":[{"period":"1week","weight":0.0027},{"period":"1month","weight":0.0024},{"period":"3month","weight":0.0483},{"period":"6month","weight":0.1499},{"period":"1year","weight":0.2011},{"period":"ytd","weight":0.1338}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with immunoglobulin A nephropathy; and for treatment of lupus nephritis. It is also developing MAU868, a monoclonal antibody for the treatment of BK viremia infections. The company was formerly known as Trucode Gene Repair, Inc. and changed its name to Vera Therapeutics, Inc. in April 2020. Vera Therapeutics, Inc. was incorporated in 2016 and is headquartered in Brisbane, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":0.057587},{"month":2,"riseRate":0.4,"avgChangeRate":0.015839},{"month":3,"riseRate":0.4,"avgChangeRate":-0.047765},{"month":4,"riseRate":0,"avgChangeRate":-0.103447},{"month":5,"riseRate":0.2,"avgChangeRate":-0.049498},{"month":6,"riseRate":0.5,"avgChangeRate":0.171762},{"month":7,"riseRate":0.666667,"avgChangeRate":0.072704},{"month":8,"riseRate":0.666667,"avgChangeRate":0.026207},{"month":9,"riseRate":0.666667,"avgChangeRate":0.078506},{"month":10,"riseRate":0.2,"avgChangeRate":-0.071412},{"month":11,"riseRate":0.8,"avgChangeRate":0.292871},{"month":12,"riseRate":0.6,"avgChangeRate":0.07812}],"exchange":"NASDAQ","name":"Vera Therapeutics, Inc.","nameEN":"Vera Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.49.0","shortVersion":"4.49.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Vera Therapeutics, Inc.(VERA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Vera Therapeutics, Inc.(VERA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Vera Therapeutics, Inc.,VERA,Vera Therapeutics, Inc.股票,Vera Therapeutics, Inc.股票老虎,Vera Therapeutics, Inc.股票老虎国际,Vera Therapeutics, Inc.行情,Vera Therapeutics, Inc.股票行情,Vera Therapeutics, Inc.股价,Vera Therapeutics, Inc.股市,Vera Therapeutics, Inc.股票价格,Vera Therapeutics, Inc.股票交易,Vera Therapeutics, Inc.股票购买,Vera Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Vera Therapeutics, Inc.(VERA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Vera Therapeutics, Inc.(VERA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}